However, there is a lack of comprehensive pan-cancer analysis of the clinical value and genetic mutations of RNF43, and the exact roles of RNF43 in modulating cancer progression and tumor immune microenvironment are still largely unknown. Here, RNF43 is linked to neoplasm.